Juan Carlos
Ruiz San Millán
Publikationen, an denen er mitarbeitet Juan Carlos Ruiz San Millán (11)
2023
-
Lymphoproliferative disorders after renal transplantation along 2 decades: A large longitudinal study of 21,546 recipients
Nefrologia, Vol. 43, Núm. 4, pp. 427-434
-
Lymphoproliferative disorders after renal transplantation along 2 decades: a large longitudinal study of 21.546 recipients
Nefrologia, Vol. 43, Núm. 4, pp. 427-434
-
Update of the recommendations on the management of the SARS-CoV-2 coronavirus pandemic (COVID-19) in kidney transplant patients
Nefrologia, Vol. 43, Núm. 5, pp. 531-545
2020
-
Recommendations on management of the SARS-CoV-2 coronavirus pandemic (Covid-19) in kidney transplant patients
Nefrologia, Vol. 40, Núm. 3, pp. 265-271
-
Use of tocilizumab in kidney transplant recipients with COVID-19
American Journal of Transplantation, Vol. 20, Núm. 11, pp. 3182-3190
2019
-
Direct-Acting Antivirals for the Treatment of Kidney Transplant Patients with Chronic Hepatitis C Virus Infection in Spain: A Long-Term Prospective Observational Study
Transplantation Direct, Vol. 5, Núm. 12
-
Early outcomes of kidney transplantation from elderly donors after circulatory death (GEODAS study)
BMC Nephrology, Vol. 20, Núm. 1
2015
-
Medium-Term Renal Function in a Large Cohort of Stable Kidney Transplant Recipients Converted from Twice-Daily to Once-Daily Tacrolimus
Transplantation Direct, Vol. 1, Núm. 7, pp. E24
2012
-
Management of proteinuria in clinical practice after kidney transplantation
Transplantation Reviews, Vol. 26, Núm. 1, pp. 36-43
2011
-
Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients
American Journal of Transplantation, Vol. 11, Núm. 9, pp. 1965-1971
2007
-
Use of the New Proliferation Signal Inhibitor Everolimus in Renal Transplant Patients in Spain: Preliminary Results of the EVERODATA Registry
Transplantation Proceedings, Vol. 39, Núm. 7, pp. 2157-2159